Iluvien Implant
Product Images NDC 68611-190

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Iluvien (NDC 68611-190). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ani Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Iluvien-figure-1 (Iluvien Figure 1)

A line graph depicting mean intraocular pressure (mm Hg) over 36 months comparing ILUVIEN (N=375) and Sham (N=185) groups. The y-axis shows intraocular pressure ranging from 0 to 25 mm Hg, and the x-axis represents time in months from 0 to 36. ILUVIEN data points are represented by a solid line, and Sham by a dashed line.*

FDA Label Image

Iluvien-figure-2 (Iluvien Figure 2)

Chemical structure diagram of fluocinolone acetonide, the active ingredient in Iluvien 0.19 mg intravitreal implant by ANI Pharmaceuticals, Inc. The image shows the molecular framework including fused rings and functional groups characteristic of this corticosteroid compound.*

FDA Label Image

Iluvien-figure-3 (Iluvien Figure 3)

Four line graphs showing the proportion (%) of subjects gaining 15 or more letters over 36 months in two studies. Each study compares phakic and pseudophakic subjects receiving ILUVIEN implant or sham treatment. ILUVIEN is represented by a solid line, and sham by a dotted line. The charts display data trends for visual acuity improvement by month for each group.*

FDA Label Image

Iluvien-figure-4 (Iluvien Figure 4)

Four line graphs from two studies showing mean change from baseline in BCVA (letters) over 36 months, comparing ILUVIEN fluocinolone acetonide implant versus sham treatment. Graphs separate phakic and pseudophakic subjects, with ILUVIEN groups showing generally greater improvements in BCVA letters over time.*

FDA Label Image

Carton (Iluvien Figure 5)

Packaging label for Iluvien 0.19 mg intravitreal implant with active ingredient fluocinolone acetonide. The label includes images of the Iluvien implant delivery device in white and blue. Manufacturer Alimera Sciences, Inc. is listed with address, and the package states sterility and prescription-only use. Storage temperature instructions and a QR code are visible on the label.*

FDA Label Image

Lid (Iluvien Figure 6)

Label for Iluvien 0.19 mg intravitreal implant containing fluocinolone acetonide. The label indicates it is sterile and for prescription use only. Storage instructions are to keep at 15° to 30°C. The label includes areas for lot number and expiration date and shows the Alimera Sciences brand on a yellow accent panel.*

FDA Label Image

Inserter (Iluvien Figure 7)

Imaging of the Iluvien fluocinolone acetonide 0.19 mg intravitreal implant delivery pen. The pen is white with a blue grip area and the brand name Iluvien clearly printed on its side. No carton or additional labeling information is shown.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.